检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]衡阳医学院心血管病研究所
出 处:《中国动脉硬化杂志》1995年第3期229-230,共2页Chinese Journal of Arteriosclerosis
摘 要:内皮细胞损伤和血管平滑肌细胞增殖在动脉粥样硬化发生发展过程中起关键作用,本工作用离休冠状动脉实验证明硝普钠呈剂量依赖性松弛冠状动脉,且与内皮去除与否无关。用噻唑蓝比色法观察到硝普钠也能剂量依赖性抑制主动脉平滑肌细胞增殖。结果表明,NO对于滑肌细胞增殖具有调节作用。提示在临床上对于动脉粥样硬化及冠心病病人,长期使用硝普钠等与NO合成及释放有关的硝基化合物不仅可以缓解冠状动脉痉挛,而且还可抑制平滑肌细胞增殖,可能有助于延缓动脉粥样硬化的进一步发展。Vascular endothelial cell damage and excessive smooth muscle cell (SMC) proliferation are considered to paly a key role in the development of a atherosclerotic disease. In present study, it was Observed that nitric oxide-generating vasodilator-sodium nitroprosside (SNP) induced endothelium-independent relaxation on porcine coronary arterial rings and inhibited mitogenesis and proliferation of cultured procine vascular smooth muscle cells in dose-dependent manner with MTT colorimetric assay. The results suggest that endogenous nitric oxide (NO) may play an important role as medulator of smooth muscle cell growth, and the long-term administration of SNP and other nitrovasodilators which release NO in the body favors inhibiting the development of atherosclerosis to patients with atherosclerotic disease.
分 类 号:R543.505[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.145